15
Views
7
CrossRef citations to date
0
Altmetric
Research Article

MicroCRP: a highly sensitive CRP method applied in the monitoring of renal allograft recipients

, , &
Pages 405-416 | Published online: 08 Jul 2009

REFERENCES

  • Harris KR, Digard NJ, Lee HA. Serum C-reactive protein. A useful and economical marker of immune activation in renal transplantation. Trans-plantation 1996; 61: 1593–600.
  • Hartmann A, Eide TC, Fauchald P, Bentdal 0, Herbert J, Gallimore JR, Pepys MB. Serum amyloid A protein is a clinically useful indicator of acute renal allograft rejection. Nephrol Dial Transplant 1997; 12: 161–6.
  • Cho WH, Kim HT, Sohn CY, Park CH, Park SB, Kim HC. Significance of IL-2, IL-2R, IL-6, and TNF-Alpha as a diagnostic test of acute rejection after renal transplantation. Transplant Proc 1998; 30: 2967–9.
  • Liuzzo G, Biasucci LM, Gallimore JR, Grillo RL, Rebuzzi AG, Pepys MB, Maseri A. The prog-nostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl. J Med 1994; 331: 417–24.
  • Mach F, Lovis C, Gaspoz JM, Unger PF, Bouillie M, Urban P, Rutishauser W. C-reactive protein as a marker for acute coronary syndroms. Eur Heart J 1997; 18: 1897–902.
  • Ridker PM, Cushman M, Stampffer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin and the risk of cardiovascular disease in apperently healthy men. N Engl J Med 1997; 336: 973–9.
  • Haverkate F, Thompson SG, Pyke SDM, Gallimore JR, Pepys MB. Production of C-reactive protein and the risk of coronary events in stable and unstable angina. Lancet 1997; 349: 462–6.
  • Meriö L, Petterson K, Lövgren T. Monoclonal antobody-based dual-label time-resolved fluoro-metric assays in a simplefied one-step format. Clin Chem 1996; 42: 1513–7.
  • Albrechtsen D, Leivestad T, Fauchald P, Flatmark A, Social G, Thorsby E. Results of the national kidney transplantation program in Norway In Terasaki PI, Cecka JM, eds. Clinical transplants 1992. Los Angeles: UCLA Tissue Typing Laboratory, 1992: 207–13.
  • Solez K, Axelsen RA, Benediktsson H, Burdick JF, Cohen AH, Colvin RB, Croker BP, Droz D, Dunnill MS, Halloran PF. International standar-dization of criteria for the histologic diagnosis of renal allografdt rejection: The BANFF working classification of kidney transplant pathology. Kidney Int 1993; 44: 411–22.
  • Solberg HE, IFCC, EPTRV. The theory of reference values. Part 5. Statistical treatment of collected reference values. Determination of refer-ence limits. J Clin Chem Clin Biochem 1983; 21: 749— 60.
  • Fuentes-Arderiu X. Clarification paper on sensi-tivity, detectability, and limit of detection. J Int Fed Clin Chem 1992; 4: 76–8.
  • Claus DR, Osmand AP, Gewurz H. Radioimmun-assay of human C-reactive protein and levels in normal sera. J Lab Clin Med 1976; 87: 120–8.
  • Macy EM, Hayes TE, Tracy RP. Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications. Clin Chem 1997; 43: 52 — 8.
  • Wilkins J, Gallimore JR, Moore EG, Pepys B. Rapid automated high sensitivity enzyme immu-noassay of C-reactive protein. Clin Chem 1998; 44: 1358— 61.
  • Koenig W, Sund M, Frohloch M, Fischer H-G, Lowel H, Doring A, Hutchinson WL, Pepys MB. C-reactive protein, a sensitive marker of inflam-mation, predicts future risk of coronary heart disease in initially healthy middle-aged med: results from the MONICA (monitoring trends and determinants in cardiovascular disease). Cir-culation 1999; 99: 237–42.
  • Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Plasma concentration of C-reactive protein and risk of developing periph-eral vascular disease. Circulation 1998; 97: 425–8.
  • van Gelder T, Balk AHMM, Zondervan PE, Maat AWPM, Mochtar B, van der Meer P, Weimar W. C-reactive protein in the monitoring of acute rejection after heart transplantation. Transpl. Int 1998; 11: 361–4.
  • Ledue TB, Weiner DL, Sipe JD, Poulin SE. Analytical evaluation of particle-enhanced immu-nonephlometric assays for C-reactive protein, serum amyloid A and mannose-binding protein in human serum. Ann Clin Biochem 1998; 35: 745–53.
  • Eda S, Kaufman J, Roos W, Pohl S. Develope-ment of a new microparticle-enhanced turbidi-metric assay for C-reactive protein with superior features in analytical sensitivity and dynamic range. J Clin Lab Anal 1998; 12: 137–44.
  • Newstead CG, Lamb WR, Brenchley PEC, Short CD. Serum and Urine IL-6 and TNF-a in renal transplant recipients with graft dysfunsction. Transplantation 1993; 56: 831–5.
  • Kutukculer N, Clark K, Rigg CKM, Forsythe JLR, Proud G, Taylor RMR, Shenton BK. The value of posttransplant monitoring of interleukin (IL)-2, IL-3, IL-4, IL-6, IL-8, and soluble CD23 in the plasma of renal allograft recipients. Trans-plantation 1995; 59: 333–40.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.